Chemo-sEVs release in cisplatin-resistance ovarian cancer cells are regulated by the lysosomal function
Ovarian cancer (OvCa) is an aggressive disease usually treated with cisplatin (CDDP)-based therapy. However, among the different types of cancers treated with CDDP, OvCa commonly develops chemoresistance to this treatment. The small extracellular vesicles (sEVs) play a central role in chemoresistanc...
Saved in:
Published in | bioRxiv |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Paper |
Language | English |
Published |
Cold Spring Harbor
Cold Spring Harbor Laboratory Press
04.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!